Global pharma major Lupin Limited (Lupin) announced the launch of the United States Food and Drug Administration (FDA) approved Minzoya (levonorgestrel and ethinyl estradiol tablets, USP and ferrous bisglycinate tablets), 0.1 mg/0.02 mg and 36.5 mg.
Minzoya (levonorgestrel and ethinyl estradiol tablets, USP and ferrous bisglycinate tablets) 0.1 mg/0.02 mg and 36.5 mg is a generic equivalent of Balcoltra (levonorgestrel and ethinyl estradiol tablets, USP and ferrous bisglycinate tablets) 0.1 mg/0.02 mg and 36.5 mg, of Avion Pharmaceuticals LLC., indicated for use by females of reproductive potential to prevent pregnancy.
Levonorgestrel and ethinyl estradiol tablets, USP and ferrous bisglycinate tablets (Balcoltra) had an estimated annual sale of USD 24 million in the US
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!